SIONNA THERAPEUTICS, INC.
Cash Flow Statement
| Line Item | FY2025 | FY2024 |
|---|---|---|
| Operating Activities | ||
| Net Income | $-75.3M | $-61.7M |
| Depreciation & Amortization | — | — |
| Depreciation | $647.0K | $668.0K |
| Amortization | — | — |
| Stock-Based Compensation | $12.1M | $3.7M |
| Net Cash from Operating Activities | $-66.3M | $-52.8M |
| Investing Activities | ||
| Capital Expenditures | $377.0K | $27.0K |
| Business Acquisitions | — | — |
| Net Cash from Investing Activities | $-118.7M | $-126.9M |
| Financing Activities | ||
| Dividends Paid | — | — |
| Stock Repurchases | — | — |
| Net Cash from Financing Activities | $205.7M | $179.0M |
| Net Change in Cash | $20.7M | $-733.0K |
| Free Cash Flow | $-66.7M | $-52.8M |